Expression of lactate/H+ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemicat and The Cancer Genome Atlas data analyses
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Younghye | - |
dc.contributor.author | Choi, Jung-Woo | - |
dc.contributor.author | Lee, Ju-Han | - |
dc.contributor.author | Kim, Young-Sik | - |
dc.date.accessioned | 2021-09-04T20:24:41Z | - |
dc.date.available | 2021-09-04T20:24:41Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 0046-8177 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94749 | - |
dc.description.abstract | Clear cell renal cell carcinomas (ccRCCs) have inactivation of the von Hippel-Lindau protein, leading to the accumulation of hypoxia-inducible factor-alpha (HIF-alpha). HIF-1 alpha induces aerobic glycolysis, the Warburg effect, whereas HIF-2 alpha functions as an oncoprotein. Lactate transport through monocarboxylate transporters (MCTs) and the chaperone CD147 is essential for high glycolytic cancer cell survival. To elucidate the clinical significance of MCT1, MCT4, and CD147 expression, we investigated their expressions by immunohistochemistry in ccRCC specimens and validated the results by an open-access The Cancer Genome Atlas data analysis. Overexpression of MCT1, MCT4, and CD147 was observed in 49.4% (89/180), 39.4% (71/180), and 79.4% (143/180) of ccRCC patients, respectively. High MCT1 expression was associated with older age (P = .017), larger tumor size (P = .015), and advanced TNM stage (P = .012). However, MCT4 overexpression was not related to any variables. CD147 overexpression correlated with high grade (P = .005), tumor necrosis (P = .016), and larger tumor size (P = .038). In univariate analysis, high expression of MCT1 (P < .001), MCT4 (P = .016), and CD147 (P = .02) was linked to short progression-free survival. In multivariate analysis, high MCT1 expression was associated with worse progression-free survival (P = .001). In conclusion, high expression of MCT1 and CD147 is associated with poor prognostic factors. Overexpression of MCT1, MCT4, and CD147 predicts tumor progression. Reversing the Warburg effect by targeting the lactate transporters may be a useful strategy to prevent ccRCC progression. (C) 2014 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | - |
dc.subject | MONOCARBOXYLATE TRANSPORTERS 1 | - |
dc.subject | THERAPEUTIC TARGET | - |
dc.subject | SURVIVAL | - |
dc.subject | GLYCOLYSIS | - |
dc.subject | METABOLISM | - |
dc.subject | BIOMARKERS | - |
dc.subject | HYPOXIA | - |
dc.subject | EMMPRIN | - |
dc.subject | GROWTH | - |
dc.subject | EXPORT | - |
dc.title | Expression of lactate/H+ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemicat and The Cancer Genome Atlas data analyses | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Jung-Woo | - |
dc.contributor.affiliatedAuthor | Lee, Ju-Han | - |
dc.contributor.affiliatedAuthor | Kim, Young-Sik | - |
dc.identifier.doi | 10.1016/j.humpath.2014.09.013 | - |
dc.identifier.scopusid | 2-s2.0-84916224406 | - |
dc.identifier.wosid | 000346540100013 | - |
dc.identifier.bibliographicCitation | HUMAN PATHOLOGY, v.46, no.1, pp.104 - 112 | - |
dc.relation.isPartOf | HUMAN PATHOLOGY | - |
dc.citation.title | HUMAN PATHOLOGY | - |
dc.citation.volume | 46 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 104 | - |
dc.citation.endPage | 112 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordPlus | MONOCARBOXYLATE TRANSPORTERS 1 | - |
dc.subject.keywordPlus | THERAPEUTIC TARGET | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | GLYCOLYSIS | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | BIOMARKERS | - |
dc.subject.keywordPlus | HYPOXIA | - |
dc.subject.keywordPlus | EMMPRIN | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | EXPORT | - |
dc.subject.keywordAuthor | Renal cell carcinoma | - |
dc.subject.keywordAuthor | Monocarboxylate | - |
dc.subject.keywordAuthor | CDI47 | - |
dc.subject.keywordAuthor | Aerobic glycolysis | - |
dc.subject.keywordAuthor | TCGA | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.